British actuary Benjamin Gompertz mathematically showed human mortality risk increases exponentially with age, framing aging as a quantifiable biological process and laying groundwork for future longevity science and actuarial models.

Nobel laureate Élie Metchnikoff introduced the term gerontology, arguing scientific study could conquer decline, elevating aging research from philosophical musings to a legitimate biomedical discipline focused on extending human life.

Clive McCay demonstrated that laboratory mice fed lifelong calorie-restricted diets lived longer and healthier, igniting decades of metabolism research linking reduced nutrient intake to delayed aging and disease across species.

Elizabeth Blackburn identified telomerase, an enzyme preserving chromosome-end telomeres, revealing a molecular clock that limits cellular divisions and inspiring strategies aimed at stabilizing genome integrity to slow aging-related processes.

Leonard Hayflick proved normal human fibroblasts divide only around sixty times before entering senescence, overturning immortality dogma and linking cellular replication ceilings to organismal aging and cancer evolutionary defense mechanisms.

MIT researchers isolated Silent Information Regulator genes controlling chromatin silencing in yeast, revealing genetic pathways that modulate lifespan and sparking comparative studies of sirtuins across species, including potential pharmacological activation.

Thomas Johnson’s age-1 mutation in C. elegans extended lifespan twofold, proving single gene alterations can dramatically delay aging and inaugurating molecular genetics as a roadmap to uncover longevity signaling networks.

Cynthia Kenyon revealed mutations in daf-2, encoding an insulin-like receptor, could double worm lifespan, linking nutrient-sensing endocrine signaling to aging control and encouraging search for conserved metabolic interventions in mammals.

Shinya Yamanaka reprogrammed adult mouse fibroblasts into induced pluripotent stem cells using four transcription factors, demonstrating cellular age can reset, inspiring hopes of tissue regeneration and eventually reversing systemic aging.

Groundbreaking review distilled disparate aging research into nine interconnected cellular and molecular hallmarks, creating a shared framework that guides therapeutic development, biomarker discovery, and public communication of longevity science worldwide

David Sinclair’s team used Yamanaka factors transiently in adult mice to regenerate retinal neurons and reverse age-related blindness, providing powerful proof that partial cellular reprogramming can safely rejuvenate mammalian tissues.

Google DeepMind released AlphaFold database predicting structures for over two hundred million proteins, dramatically accelerating target identification, drug design and systems biology for aging interventions without expensive laboratory crystallography experiments.